Nasopharynx (excluding Malignant Melanoma)
Primary Site | Histology | Schema Discriminator: Nasopharynx/PharyngealTonsil | Staging Type |
---|---|---|---|
C110, C112-C113, C118-C119 | 8000-8576, 8940-8950, 8980-8981 | <Any value> | TNM 7 and Summary Stage |
C110, C112-C113, C118-C119 | 8577-8713, 8800-8939, 8951-8979, 8982-9136, 9141-9582, 9700-9701 | <Any value> | Summary Stage only |
C111 | 8000-8576, 8940-8950, 8980-8981 | 010 | TNM 7 and Summary Stage |
C111 | 8577-8713, 8800-8939, 8951-8979, 8982-9136, 9141-9582, 9700-9701 | 010 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C110 Superior wall of nasopharynx C111 Posterior wall of nasopharynx (excluding pharyngeal tonsil) C112 Lateral wall of nasopharynx C113 Anterior wall of nasopharynx C118 Overlapping lesion of nasopharynx C119 Nasopharynx, NOS **Note 1:** This schema is based on the UICC chapter *Pharynx,* pages 30-38. * Primary sites C118 and C119 are listed in the chapter heading but are not specified in the anatomic subsites in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met * **Site-Specific Factor 25, Nasopharynx/PharyngealTonsil** is used to discriminate between posterior wall of nasopharynx, staged with nasopharynx, and pharyngeal tonsil, staged with oropharynx. Both sites are coded to ICD-O-3 code C111 **Note 2:** The margin of the choanal orifices, including the posterior margin of the nasal septum, is included with the nasal fossa. **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Nasopharynx* chapter on page 62 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=62).Main Data Items
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Behavior | <BLANK> | Yes | NAACCR #523 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |